ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	33/549	57/5488	3.10785602219737e-19	1.40785877805541e-16	1.19079957061036e-16	6356/6357/6362/6347/6364/6368/6369/6348/6351/6355/1440/6376/2919/3627/6373/58191/2920/2921/6374/6372/4283/3589/3552/3553/3557/11009/90865/3569/4312/4314/5008/6696/8741	33
WP5055	Burn wound healing	40/549	91/5488	2.19417370124469e-17	4.96980343331922e-15	4.2035748802793e-15	8038/6347/57124/1139/1277/1278/2919/3579/1634/2200/2335/3082/3383/3552/3553/3569/3624/3791/3956/23643/4312/4322/4313/79148/4314/64332/64127/5159/6282/6280/8796/871/6423/6678/7043/7076/7097/7099/51311/3371	40
WP558	Complement and coagulation cascades	27/549	45/5488	1.69089049499298e-16	2.55324464743939e-14	2.15959347430682e-14	712/713/715/716/717/719/721/728/729/1604/629/3075/3426/1380/2149/2152/2153/3827/5648/5327/5328/5329/5104/5054/710/7056/7450	27
WP2806	Complement system	33/549	73/5488	5.56064651576035e-15	6.2974321790986e-13	5.32651403088623e-13	133/715/716/717/719/720/722/728/729/1604/22918/629/3075/3426/1380/1634/2214/2219/2357/2769/3383/3673/3687/3690/3915/5648/5329/5806/6401/6403/710/6696/7097	33
WP5115	Network map of SARS-CoV-2 signaling pathway	54/549	180/5488	2.19204892398134e-14	1.98599632512709e-12	1.6798017017457e-12	8542/684/715/716/838/6356/6347/6364/6348/6351/6355/929/9332/1051/629/3075/3426/1294/1508/1514/2919/3627/58191/2920/2921/6374/6372/4283/3577/3579/84985/2247/2335/3091/10964/2537/8519/10410/8807/3552/3553/90865/3569/3699/116844/64386/114548/5743/6288/6289/6403/5104/5054/6772	54
WP2911	miRNA targets in ECM and membrane receptors	15/549	22/5488	7.36724797766707e-11	5.56227222313864e-09	4.70469870854529e-09	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/2335/22801/3910/3915/7058	15
WP3624	Lung fibrosis	20/549	48/5488	8.23348486080628e-09	5.32824091706464e-07	4.50674960802028e-07	6356/6347/6348/6351/729230/1051/1440/2920/2247/2252/26585/3082/3553/3569/4313/5155/5328/5806/6696/7076	20
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	53/549	244/5488	2.24335396432417e-08	1.27029918229856e-06	1.07444847764999e-06	284/285/1277/1278/1280/1281/1282/1284/1289/1290/50509/1292/9586/1440/1441/2149/2247/2252/2321/2335/59345/2791/3082/3091/3559/3563/3575/22801/3673/3678/8516/3687/3690/3791/284217/3908/3910/3915/10319/4843/4846/5008/9180/5155/5159/5209/5228/6515/6696/7010/7058/3371/7450	53
WP2431	Spinal cord injury	27/549	87/5488	3.93272981324482e-08	1.97947400599989e-06	1.67428497312411e-06	199/301/713/6347/729230/1280/1282/2919/3627/2920/2212/2697/3383/3552/3553/3554/3569/10288/4321/4843/9423/5320/5743/6403/7099/8741/1462	27
WP455	GPCRs, class A rhodopsin-like	27/549	88/5488	5.15010448892128e-08	2.33299733348134e-06	1.97330319364984e-06	187/719/1230/729230/10803/1240/3577/3579/1909/2149/2151/9002/2867/2357/2358/2359/23432/8111/8843/4886/5540/53829/9934/5031/5724/5737/56670	27
WP129	Matrix metalloproteinases	12/549	21/5488	1.1287921433783e-07	4.64857128136701e-06	3.93186928411199e-06	4312/4319/4321/4322/4323/4327/4313/64386/79148/4314/4316/7076	12
WP545	Complement activation	11/549	18/5488	1.50902181296504e-07	5.69655734394301e-06	4.81828017473047e-06	712/713/715/716/717/720/721/729/1604/629/5648	11
WP24	Peptide GPCRs	13/549	27/5488	4.68092973240591e-07	1.63112397598452e-05	1.37964244744595e-05	719/728/1230/729230/10803/3577/3579/1909/2357/2358/2359/4886/5540	13
WP4754	IL-18 signaling pathway	47/549	228/5488	7.56189797552163e-07	2.44681413065093e-05	2.06957207751118e-05	59/11096/6362/6347/6364/6348/6351/1051/9076/1277/1278/1281/58191/2920/2921/2335/338442/3383/8870/10068/8809/8807/3553/3559/3569/3659/4312/4322/4323/4313/4314/4688/4776/64332/4843/51299/7941/5743/5806/9021/6696/7052/7076/7127/4982/79931/80149	47
WP4172	PI3K-Akt signaling pathway	51/549	259/5488	1.09525576203954e-06	3.3076724013594e-05	2.7977059465431e-05	284/285/1277/1278/1280/1282/1284/1291/1292/1293/9586/1440/1441/2149/2247/2252/2321/2335/59345/2791/3082/3559/3563/3569/3575/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/4846/4915/5008/9180/5155/5159/5228/8503/6696/7010/7058/7097/7099/3371/7450	51
WP5090	Complement system in neuronal development and plasticity	24/549	84/5488	1.2337805214099e-06	3.49314110124177e-05	2.95457966969212e-05	712/713/715/716/717/719/720/721/722/725/728/729/1604/629/3075/3426/1380/6376/2219/3687/3690/5648/710/7043	24
WP5088	Prostaglandin signaling	12/549	26/5488	2.31373392057881e-06	6.16542038836589e-05	5.21485539994234e-05	834/6347/6348/729230/2919/3627/4283/3552/3553/3569/114548/9536	12
WP3967	miR-509-3p alteration of YAP1/ECM axis	9/549	16/5488	5.65516527900492e-06	0.000142321659521624	0.000120378956816245	1277/1281/1289/1909/2335/10082/6678/7004/7058	9
WP619	Type II interferon signaling	13/549	33/5488	7.58012711371017e-06	0.000180726188553195	0.00015286239719615	3627/4283/2633/3383/2537/3553/3659/4843/5698/9021/6688/6772/6890	13
WP2865	IL1 and megakaryocytes in obesity	10/549	21/5488	1.17687806029662e-05	0.000266562880657183	0.000225465059972615	6347/2149/3383/3553/3554/114548/7941/6280/7076/7097	10
WP5087	Malignant pleural mesothelioma	60/549	356/5488	2.3883351097649e-05	0.000515198002249285	0.000435766405992192	59/9510/284/285/834/6347/6351/29126/1009/1012/1001/1003/1004/1282/1284/1440/115908/2919/3627/6374/2247/2252/2321/2335/3082/3091/3620/3553/3569/3673/3690/3791/284217/3908/3910/3915/10319/26524/4323/4313/4314/114548/4915/5155/5159/5163/5228/5328/5420/4920/6401/6422/6423/8140/6678/6772/7004/7010/7474/25937	60
WP4462	Platelet-mediated interactions with vascular and circulating cells	8/549	15/5488	3.24718052608123e-05	0.000668623990143089	0.000565537661001707	6347/3383/3553/6401/6403/7043/7097/7099	8
WP2328	Allograft rejection	19/549	70/5488	3.55099715148771e-05	0.000699392047662579	0.00059156199686111	712/713/717/720/721/729/1604/941/942/1289/6373/4283/50943/3002/3552/3553/3559/120892/6772	19
WP4891	COVID-19 adverse outcome pathway	7/549	12/5488	4.88495612556278e-05	0.000922035468699975	0.000779878960396865	6347/6348/1440/3627/3553/3559/3569	7
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	12/549	34/5488	6.19204243268897e-05	0.00112199808880324	0.000949011977052119	84674/834/838/50506/3553/4210/4671/58484/114548/64127/639/8767	12
WP1533	Vitamin B12 metabolism	12/549	35/5488	8.57936897926623e-05	0.00149479005677215	0.00126432806010239	19/348/6347/3383/3553/3569/5327/6288/6289/5054/6648/6947	12
WP2848	Pluripotent stem cell differentiation pathway	10/549	26/5488	0.000111451365732836	0.00186990624729537	0.00158161002443479	3577/2247/3082/3589/3569/3624/5155/6469/7043/7474	10
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	16/549	58/5488	0.000118614875584765	0.00191901923713923	0.00162315092905468	6347/6348/6351/2919/3627/6373/2920/2921/6374/6372/4283/3579/84868/8519/3569/6772	16
WP3617	Photodynamic therapy-induced NF-kB survival signaling	11/549	32/5488	0.000165093946356537	0.00257888129998314	0.00218127754895751	597/2920/3383/3552/3553/3569/4312/4313/4314/5743/6401	11
WP306	Focal adhesion	33/549	173/5488	0.000174237464035146	0.0026309857069307	0.00222534866346642	87/1277/1278/1280/1282/1284/1290/50509/1292/2268/2321/2335/3055/3082/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/5155/5159/5228/8503/6696/7058/3371/7450	33
WP2877	Vitamin D receptor pathway	26/549	127/5488	0.000266920522460186	0.0039004837636924	0.00329911953057751	11096/768/838/929/634/1594/1555/1577/1673/50486/3091/3488/9173/3827/126364/639/6275/6279/6280/6422/219855/6696/79689/7056/4982/54210	26
WP5094	Orexin receptor pathway	22/549	101/5488	0.000315200716464325	0.0044620601424481	0.00377411384187547	2920/1846/2354/3091/3383/3553/3569/3777/3908/4023/23764/7873/4322/4314/4846/8013/5069/5163/861/6401/6696/3371	22
WP4478	LTF danger signal response pathway	7/549	16/5488	0.000493016536264486	0.00656872032140625	0.00555597582663384	929/3552/3553/3569/7097/7099/54210	7
WP530	Cytokines and inflammatory response	7/549	16/5488	0.000493016536264486	0.00656872032140625	0.00555597582663384	1440/2919/2920/3589/3552/3553/3569	7
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	9/549	26/5488	0.000616340192863706	0.00769899731864201	0.00651199029623723	6347/29126/941/942/3627/3559/7043/7099/51311	9
WP474	Endochondral ossification	14/549	54/5488	0.000628836425584446	0.00769899731864201	0.00651199029623723	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/871/6696/6772	14
WP4808	Endochondral ossification with skeletal dysplasias	14/549	54/5488	0.000628836425584446	0.00769899731864201	0.00651199029623723	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/871/6696/6772	14
WP2849	Hematopoietic stem cell differentiation	12/549	43/5488	0.000746623552928056	0.00890053867043183	0.00752828180791724	947/1440/2354/2624/3552/3553/3569/3690/4582/861/6688/7068	12
WP4538	Regulatory circuits of the STAT3 signaling pathway	16/549	68/5488	0.000844687320697617	0.00981136810964155	0.00829868244895905	1271/1438/1439/1441/2149/2151/9002/3595/3601/3559/3563/3575/9180/5159/80854/9021	16
WP12	Osteoclast signaling	6/549	14/5488	0.00145081276820615	0.0156480519999377	0.0132354849029333	1513/8111/3690/5155/6696/4982	6
WP272	Blood clotting cascade	6/549	14/5488	0.00145081276820615	0.0156480519999377	0.0132354849029333	2152/2153/5327/5328/5054/7450	6
WP5063	FOXP3 in COVID-19	6/549	14/5488	0.00145081276820615	0.0156480519999377	0.0132354849029333	941/942/50943/3559/3569/3575	6
WP1539	Angiogenesis	8/549	24/5488	0.00164164427333501	0.0161953829706369	0.013698430118071	284/2247/2321/3091/3791/4846/5155/7010	8
WP453	Inflammatory response pathway	8/549	24/5488	0.00164164427333501	0.0161953829706369	0.013698430118071	941/942/1277/1278/1281/2335/3559/3915	8
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/549	19/5488	0.0016620957128522	0.0161953829706369	0.013698430118071	2919/2920/2247/3553/5155/6469/30812	7
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	10/549	35/5488	0.00168031567245019	0.0161953829706369	0.013698430118071	284/285/597/3091/3485/4843/5743/5054/6515/7043	10
WP4136	Fibrin complement receptor 3 signaling pathway	10/549	35/5488	0.00168031567245019	0.0161953829706369	0.013698430118071	6347/929/3627/2921/3569/23643/4843/5327/7099/7305	10
WP4541	Hippo-Merlin signaling dysregulation	19/549	94/5488	0.00203993017929352	0.0192518410670826	0.0162836531855886	1009/1012/1001/1003/1004/3627/2321/22801/3673/3678/8516/3687/3690/3791/26524/4915/5159/7004/7010	19
WP4329	miRNAs involvement in the immune response in sepsis	10/549	36/5488	0.00212271246385271	0.0196242601250056	0.0165986538526828	6348/6351/3002/3383/3552/3569/3659/3934/7099/51311	10
WP4494	Selective expression of chemokine receptors during T-cell polarization	7/549	20/5488	0.00233977510683867	0.0211983624679583	0.0179300660818795	6348/6351/1230/729230/3595/8809/7043	7
WP15	Selenium micronutrient network	13/549	55/5488	0.0024313964053605	0.0215965210123197	0.0182668378029148	19/6347/3383/3553/3569/8942/5327/10549/5743/6288/6289/5054/6648	13
WP5198	Inflammatory bowel disease signaling	9/549	31/5488	0.00252179089638051	0.0219686783857764	0.0185816171312248	50943/3595/8807/3552/3569/64127/6772/7097/7099	9
WP4493	Cells and molecules involved in local acute inflammatory response 	6/549	16/5488	0.00324954626391912	0.0277744237274597	0.023492251044023	729/3383/3552/3569/3827/6403	6
WP75	Toll-like receptor signaling pathway	17/549	84/5488	0.00339887958092573	0.0285128231510992	0.0241168063831767	6348/6351/929/941/942/3627/6373/4283/3553/3569/23643/8503/6696/6772/7097/7099/51311	17
WP176	Folate metabolism	11/549	46/5488	0.00467364667916155	0.0384938535574579	0.0325589931332977	19/6347/3383/3553/3569/10797/5327/6288/6289/5054/6648	11
WP3929	Chemokine signaling pathway	24/549	140/5488	0.00564206440607347	0.04564027099913	0.0386035985678711	6356/6364/6369/6348/6351/1230/729230/10803/6376/3627/6373/58191/2921/6374/4283/3579/2268/2770/59345/2791/3055/8503/23236/6772	24
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	5/549	13/5488	0.0063996319401872	0.0508602327878036	0.0430187631805751	19/348/9388/4023/255738	5
WP5218	Extrafollicular B cell activation by SARS-CoV-2	13/549	62/5488	0.00726104524752298	0.0563170680456567	0.0476342808612038	57379/60468/720/941/1380/8519/3569/3687/639/57823/7099/8741/7494	13
WP2197	Endothelin pathways	7/549	24/5488	0.00733489407217163	0.0563170680456567	0.0476342808612038	10203/1909/2769/2770/4846/4886/23236	7
WP4496	Signal transduction through IL1R	8/549	30/5488	0.00762856287917407	0.0575956497377642	0.0487157348775326	3552/3553/3554/3556/3557/3569/11213/7043	8
WP3937	Microglia pathogen phagocytosis pathway	9/549	37/5488	0.0090435098662315	0.0671591798262765	0.0568047901865102	712/713/2207/2209/3055/4688/8503/54210/7305	9
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	11/549	51/5488	0.0105494904358526	0.0770793414103424	0.0651954926765764	947/27122/2354/2619/3488/8549/22822/6275/6422/11005/7474	11
WP4747	Netrin-UNC5B signaling pathway	10/549	45/5488	0.0117253329766071	0.0843107275936986	0.071311966641353	249/6347/1003/1277/3383/3552/3791/9423/54538/6401	10
WP289	Myometrial relaxation and contraction pathways	20/549	118/5488	0.0124090571247521	0.0878328574611358	0.0742910656810815	59/133/800/2697/59345/2791/3485/3488/3553/3569/23764/4846/5142/5333/10266/10268/64407/5999/8490/8787	20
WP5188	Retinol metabolism	4/549	10/5488	0.0127260308590303	0.0883251519310727	0.0747074597488334	316/1551/10170/195814	4
WP98	Prostaglandin synthesis and regulation	9/549	39/5488	0.0128685651820106	0.0883251519310727	0.0747074597488334	1645/301/308/1909/3290/9536/5737/5743/6916	9
WP117	GPCRs, other	7/549	27/5488	0.0144612951177007	0.0963377454164473	0.0814846969480349	3577/3579/1909/2149/11245/53829/5737	7
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	7/549	27/5488	0.0144612951177007	0.0963377454164473	0.0814846969480349	6347/2977/3553/3569/4312/4314/23657	7
WP3941	Oxidative damage response	9/549	40/5488	0.0151791113239559	0.0996541656485797	0.0842898020125085	712/713/715/716/717/719/721/728/1380	9
WP3287	Overview of nanoparticle effects	5/549	16/5488	0.0168728099948111	0.107653280671119	0.0910556388155857	1001/1282/2335/3569/5743	5
WP3413	NOTCH1 regulation of endothelial cell calcification	5/549	16/5488	0.0168728099948111	0.107653280671119	0.0910556388155857	249/813/2702/4256/5327	5
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	7/549	28/5488	0.0176670561094924	0.108212516320448	0.0915286532837068	9509/1277/1278/60681/4015/871/4982	7
WP4823	Genes controlling nephrogenesis	7/549	28/5488	0.0176670561094924	0.108212516320448	0.0915286532837068	2737/8516/3791/5155/5159/6092/6469	7
WP4969	RAS and bradykinin pathways in COVID-19	6/549	22/5488	0.0180269651973042	0.108212516320448	0.0915286532837068	3552/3553/3827/4846/5054/710	6
WP5092	Interactions of natural killer cells in pancreatic cancer	6/549	22/5488	0.0180269651973042	0.108212516320448	0.0915286532837068	6347/6348/6351/2214/2624/3002	6
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	12/549	62/5488	0.0181548592502298	0.108212516320448	0.0915286532837068	6347/1594/1673/10964/3569/64127/23236/5333/6772/7097/7099/51311	12
WP4707	Aspirin and miRNAs	4/549	11/5488	0.0184426599556302	0.108500324154552	0.0917720878174899	283120/4846/5163/5743	4
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	10/549	50/5488	0.0240258494611174	0.139534741101105	0.118021716651103	1003/1277/1278/2321/3082/3791/4313/8829/91584/7043	10
WP5097	CCL18 signaling pathway	7/549	30/5488	0.0255157834677106	0.14272779156021	0.12072247270342	59/1278/2335/3091/4313/6772/7004	7
WP1602	Nicotine effect on dopaminergic neurons	4/549	12/5488	0.0255208633915608	0.14272779156021	0.12072247270342	1138/2770/3777/6571	4
WP4724	Omega-9 fatty acid synthesis	4/549	12/5488	0.0255208633915608	0.14272779156021	0.12072247270342	2180/2182/3992/6319	4
WP2406	Cardiac progenitor differentiation	6/549	24/5488	0.0274039782310747	0.151390269983864	0.128049397639425	2247/3624/3791/3084/4920/7070	6
WP3670	Interactions between LOXL4 and oxidative stress pathway	5/549	18/5488	0.0280051231295984	0.152847238285639	0.129281735182927	308/1280/2252/2335/3490	5
WP4210	Tryptophan catabolism leading to NAD+ production	4/549	13/5488	0.0340191884810601	0.183460623594289	0.155175245703081	3620/8942/10135/6999	4
WP727	Monoamine transport	5/549	19/5488	0.0349756804050397	0.186399802629212	0.157661271423337	3553/3554/3690/6999/4982	5
WP465	Tryptophan metabolism	7/549	32/5488	0.0354628767862897	0.186798641676619	0.157998618729614	8854/316/1545/9420/3620/8942/6999	7
WP5083	Neuroinflammation and glutamatergic signaling	16/549	100/5488	0.0385644253223783	0.200800973230315	0.169842115152398	1610/2247/116443/3552/3553/3554/3569/80131/23236/29968/6507/6515/92745/9021/6772/7043	16
WP5122	Prostaglandin and leukotriene metabolism in senescence 	6/549	26/5488	0.0395373387913694	0.20352743718739	0.1721482215318	2770/3488/23236/9536/5743/6916	6
WP43	Oxidation by cytochrome P450	7/549	34/5488	0.0476841968949556	0.242707204420392	0.205287376342565	1545/56603/1594/1555/1577/1551/9420	7
WP2374	Oncostatin M signaling pathway	11/549	64/5488	0.0506399784644338	0.254887891604317	0.215590083755016	6347/1051/3091/4312/4322/4314/5008/9180/5054/9021/6772	11
WP364	IL6 signaling pathway	8/549	42/5488	0.0533160270651077	0.265408354510921	0.22448853501098	3055/3569/3659/639/9021/6772/7076/7432	8
WP4540	Hippo signaling regulation pathways	13/549	81/5488	0.0572503384731998	0.281895688351734	0.238433903938727	1009/1012/1001/1003/1004/2321/3791/26524/4915/5159/23236/7004/7010	13
WP5222	2q13 copy number variation syndrome	8/549	43/5488	0.0600319342124422	0.292413615034799	0.247330209998064	3552/3553/3554/3556/3557/3569/9021/6772	8
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/549	22/5488	0.0618327551595253	0.297070976439407	0.251269514172056	285/2022/2200/10631/5054	5
WP4331	Neovascularisation processes	7/549	36/5488	0.0622996528956815	0.297070976439407	0.251269514172056	284/3091/3791/4854/4855/5155/7043	7
WP5110	Familial hyperlipidemia type 3	3/549	10/5488	0.0700807821249169	0.326473918712149	0.276139203929876	348/4023/7436	3
WP2118	Arrhythmogenic right ventricular cardiomyopathy	9/549	52/5488	0.0703395731737608	0.326473918712149	0.276139203929876	87/2697/22801/3673/3678/8516/3690/3908/6444	9
WP2880	Glucocorticoid receptor pathway	10/549	60/5488	0.0721043172493956	0.326473918712149	0.276139203929876	6347/6364/3589/5142/5743/5272/1836/5552/7056/84951	10
WP3945	TYROBP causal network in microglia	10/549	60/5488	0.0721043172493956	0.326473918712149	0.276139203929876	58191/3142/10261/3687/10008/4688/5341/6696/113277/7305	10
WP4900	Purinergic signaling	5/549	23/5488	0.0727899907062407	0.326473918712149	0.276139203929876	2770/5027/53829/9934/5031	5
WP5036	Angiotensin II receptor type 1 pathway	5/549	23/5488	0.0727899907062407	0.326473918712149	0.276139203929876	59/1277/1278/3091/3589	5
WP167	Eicosanoid synthesis	4/549	17/5488	0.0824195243684674	0.359000428258805	0.303650879252248	5320/9536/5743/6916	4
WP3874	Canonical and non-canonical TGF-B signaling	4/549	17/5488	0.0824195243684674	0.359000428258805	0.303650879252248	26585/4015/4016/4017	4
WP3877	MYD88 distinct input-output pathway	4/549	17/5488	0.0824195243684674	0.359000428258805	0.303650879252248	3552/7097/7099/51311	4
WP3971	OSX and miRNAs in tooth development	3/549	11/5488	0.0894450779383995	0.371730461523807	0.31441823630688	249/4854/4855	3
WP4495	IL-10 anti-inflammatory signaling pathway 	3/549	11/5488	0.0894450779383995	0.371730461523807	0.31441823630688	3552/3569/6772	3
WP4723	Omega-3 / omega-6 fatty acid synthesis	3/549	11/5488	0.0894450779383995	0.371730461523807	0.31441823630688	2180/2182/3992	3
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	3/549	11/5488	0.0894450779383995	0.371730461523807	0.31441823630688	1240/2358/5163	3
WP554	ACE inhibitor pathway	3/549	11/5488	0.0894450779383995	0.371730461523807	0.31441823630688	1511/3827/4846	3
WP3646	Hepatitis C and hepatocellular carcinoma	8/549	47/5488	0.0920129234619319	0.37649699786972	0.318449883175504	1284/3577/3091/3569/4312/4843/5420/5743	8
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	15/549	104/5488	0.0926401103616679	0.37649699786972	0.318449883175504	720/721/1051/1139/2624/2697/3091/3552/3553/3557/3569/3764/4915/6507/7068	15
WP4239	Epithelial to mesenchymal transition in colorectal cancer	17/549	121/5488	0.0931065511791796	0.37649699786972	0.318449883175504	9076/51208/9073/1282/1284/2335/3091/3678/26524/4313/4854/4855/8828/8503/6678/7043/7474	17
WP3527	Pre-implantation embryo	6/549	32/5488	0.0939164696672812	0.37649699786972	0.318449883175504	366/2354/2624/4603/30812/7004	6
WP383	Striated muscle contraction pathway	4/549	18/5488	0.0979664961510015	0.378765328342714	0.320368489640404	59/4604/7134/7169	4
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	4/549	18/5488	0.0979664961510015	0.378765328342714	0.320368489640404	3569/3791/6696/7099	4
WP4961	STING pathway in Kawasaki-like disease and COVID-19	4/549	18/5488	0.0979664961510015	0.378765328342714	0.320368489640404	2152/2212/3553/114548	4
WP5044	Kynurenine pathway and links to cell senescence	4/549	18/5488	0.0979664961510015	0.378765328342714	0.320368489640404	3620/8942/6999/7099	4
WP236	Adipogenesis	15/549	105/5488	0.0986629332106848	0.378765328342714	0.320368489640404	1051/1271/56603/2624/3091/3569/4023/10135/5008/6319/5054/9021/6695/6772/25937	15
WP2324	AGE/RAGE pathway	10/549	64/5488	0.101705494486559	0.387164613465641	0.327472799585205	249/3091/4322/4323/4313/4316/4481/4843/4846/6772	10
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/549	19/5488	0.114764047016591	0.433234277487632	0.366439588719642	941/942/3101/6515	4
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	8/549	51/5488	0.13210189178214	0.484794575991134	0.41005048370111	308/348/2149/8870/3575/3084/8767/9021	8
WP1434	Osteopontin signaling	3/549	13/5488	0.133773337745898	0.484794575991134	0.41005048370111	3690/5328/6696	3
WP3958	GPR40 pathway	3/549	13/5488	0.133773337745898	0.484794575991134	0.41005048370111	23236/5333/113026	3
WP4760	PKC-gamma calcium signaling pathway in ataxia	3/549	13/5488	0.133773337745898	0.484794575991134	0.41005048370111	2769/5163/23236	3
WP5174	Ulcerative colitis signaling	3/549	13/5488	0.133773337745898	0.484794575991134	0.41005048370111	50943/64127/7097	3
WP716	Vitamin A and carotenoid metabolism	5/549	28/5488	0.141752969181827	0.509635674915615	0.431061660669882	8854/56603/4023/29881/195814	5
WP4582	Cancer immunotherapy by CTLA4 blockade	3/549	14/5488	0.15826590072106	0.560112914270628	0.473756479132122	941/942/8503	3
WP4830	GDNF/RET signaling axis	3/549	14/5488	0.15826590072106	0.560112914270628	0.473756479132122	2737/26585/6092	3
WP3888	VEGFA-VEGFR2 signaling pathway	46/549	401/5488	0.175156096781395	0.615083037534665	0.520251482892106	9510/56999/301/81575/22899/813/6347/1003/79094/2022/2078/2152/2321/2335/6624/2624/2697/3142/5654/3383/3490/3690/3791/9079/4319/4323/4313/79812/4688/91624/4846/4855/8013/8828/5228/5328/5329/5743/5954/57381/27289/6401/6648/6772/7004/8794	46
WP4018	Clear cell renal cell carcinoma pathways	11/549	81/5488	0.182467840215661	0.626674068973171	0.530055445814417	1012/2321/3091/3101/3759/3791/5155/5159/29968/10993/7043	11
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	3/549	15/5488	0.183990399941351	0.626674068973171	0.530055445814417	1004/2335/3371	3
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	3/549	15/5488	0.183990399941351	0.626674068973171	0.530055445814417	249/1594/6696	3
WP516	Hypertrophy model	3/549	15/5488	0.183990399941351	0.626674068973171	0.530055445814417	3552/3554/8013	3
WP4197	Immune response to tuberculosis	4/549	23/5488	0.192555590984745	0.646130983082146	0.546512554529804	8519/3659/6772/6890	4
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	4/549	23/5488	0.192555590984745	0.646130983082146	0.546512554529804	9536/5737/5743/6916	4
WP4658	Small cell lung cancer	12/549	91/5488	0.195234231765241	0.650302257276871	0.550040714880402	1282/1284/2335/3673/284217/3908/3910/3915/10319/4843/8503/5743	12
WP4298	Acute viral myocarditis	10/549	74/5488	0.201496260149303	0.666261356552074	0.563539290774846	199/834/1604/941/3569/3908/64127/6444/6772/7099	10
WP4222	Phosphodiesterases in neuronal function	5/549	32/5488	0.211229583157604	0.688395691873342	0.582261024379915	1139/2977/10846/5141/5142	5
WP4542	Leukocyte-intrinsic Hippo pathway functions	5/549	32/5488	0.211229583157604	0.688395691873342	0.582261024379915	50943/26524/4023/639/7004	5
WP4950	16p11.2 distal deletion syndrome	4/549	24/5488	0.214119973541754	0.692831057245817	0.586012559166904	1380/8519/3791/5350	4
WP5130	Th17 cell differentiation pathway	8/549	58/5488	0.219603828603154	0.705535704661198	0.596758444281808	50943/3091/3553/3559/3569/861/9021/6772	8
WP2882	Nuclear receptors meta-pathway	29/549	250/5488	0.222233971397495	0.708957669317361	0.599652821265294	874/6347/6364/1545/1555/1577/1551/3082/3589/3553/55554/23764/3084/5142/5155/5743/6319/5272/1836/154091/6515/160728/11254/23657/8140/5552/27286/7056/84951	29
WP4784	Proteoglycan biosynthesis	3/549	17/5488	0.238202459574042	0.75458541389539	0.638245824695996	9469/55790/1836	3
WP4816	TGF-beta receptor signaling in skeletal dysplasias	7/549	51/5488	0.244749233705575	0.769940297698787	0.651233341146412	25805/2022/2200/3624/5054/6696/6772	7
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	8/549	60/5488	0.247895172770013	0.773856797156379	0.654546007121928	941/9076/1514/3690/5329/5420/7099/7225	8
WP4249	Hedgehog signaling pathway	5/549	34/5488	0.249410799966515	0.773856797156379	0.654546007121928	91653/2619/2737/23432/6469	5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	6/549	43/5488	0.256600898123913	0.788307793942277	0.666768994992422	19/2180/2182/9023/3992/6319	6
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2/549	10/5488	0.264006947511127	0.788307793942277	0.666768994992422	1116/9021	2
WP3630	NAD metabolism, sirtuins and aging	2/549	10/5488	0.264006947511127	0.788307793942277	0.666768994992422	3091/10135	2
WP4846	SARS-CoV-2 and COVID-19 pathway	2/549	10/5488	0.264006947511127	0.788307793942277	0.666768994992422	1514/8829	2
WP4942	15q13.3 copy number variation syndrome	2/549	10/5488	0.264006947511127	0.788307793942277	0.666768994992422	1139/871	2
WP3893	Development and heterogeneity of the ILC family	3/549	18/5488	0.26624965225865	0.788307793942277	0.666768994992422	3553/90865/3569	3
WP4533	Transcription co-factors SKI and SKIL protein partners	3/549	18/5488	0.26624965225865	0.788307793942277	0.666768994992422	26524/23314/7004	3
WP4565	Neural crest cell migration in cancer	5/549	35/5488	0.26912402468496	0.791644046638226	0.669590874814254	1009/2151/4313/4915/8503	5
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	6/549	44/5488	0.274225660445267	0.80144660762391	0.677882107993734	6356/3055/3559/3569/3575/6772	6
WP2876	Pregnane X receptor pathway	4/549	27/5488	0.282101300446065	0.813961077083232	0.688467136187514	1555/1577/1551/27286	4
WP4008	NO/cGMP/PKG mediated neuroprotection	4/549	27/5488	0.282101300446065	0.813961077083232	0.688467136187514	2977/3553/4843/4846	4
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	5/549	36/5488	0.289160510697392	0.829048805986826	0.701228686834448	684/8519/10581/10410/6196	5
WP3645	NAD+ biosynthetic pathways	3/549	19/5488	0.294653203241536	0.838716291591014	0.709405670126941	3620/10135/6999	3
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2/549	11/5488	0.302798474082845	0.838716291591014	0.709405670126941	1634/6422	2
WP4211	Transcriptional cascade regulating adipogenesis	2/549	11/5488	0.302798474082845	0.838716291591014	0.709405670126941	1051/2624	2
WP4919	Neuroinflammation	2/549	11/5488	0.302798474082845	0.838716291591014	0.709405670126941	4843/7099	2
WP4947	Nitric oxide metabolism in cystic fibrosis	2/549	11/5488	0.302798474082845	0.838716291591014	0.709405670126941	4843/4846	2
WP4241	Type 2 papillary renal cell carcinoma	4/549	28/5488	0.305492688990105	0.838716291591014	0.709405670126941	1513/3091/5155/7043	4
WP4481	Resistin as a regulator of inflammation	4/549	28/5488	0.305492688990105	0.838716291591014	0.709405670126941	3569/23236/5333/113026	4
WP3303	RAC1/PAK1/p38/MMP2 pathway	8/549	64/5488	0.307559208752398	0.839303141956846	0.709902041762036	284/285/2335/4313/4843/7010/7075/79931	8
WP4217	Ebola virus infection in host	14/549	120/5488	0.311792385703449	0.845760183974026	0.715363557491682	87/684/11314/1508/1514/26762/84868/3673/3678/3690/8503/9021/6772/7099	14
WP2858	Ectoderm differentiation	12/549	102/5488	0.320486593839169	0.864169208387759	0.730934336826175	91653/6347/1004/2737/9079/4061/5420/5783/4920/6469/6781/4982	12
WP3640	Imatinib and chronic myeloid leukemia	3/549	20/5488	0.323229058041168	0.866406883388456	0.732827014182405	2321/5159/11040	3
WP4655	Cytosolic DNA-sensing pathway	7/549	56/5488	0.326070437462006	0.868881812766405	0.734920366787432	834/6351/3627/3553/90865/3569/81030	7
WP247	Small ligand GPCRs	2/549	12/5488	0.341207539008612	0.883240086690864	0.747064927513592	5724/5737	2
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	2/549	12/5488	0.341207539008612	0.883240086690864	0.747064927513592	249/6422	2
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	2/549	12/5488	0.341207539008612	0.883240086690864	0.747064927513592	3690/7134	2
WP47	Hedgehog signaling pathway	2/549	12/5488	0.341207539008612	0.883240086690864	0.747064927513592	2737/6469	2
WP5109	Familial hyperlipidemia type 2	2/549	12/5488	0.341207539008612	0.883240086690864	0.747064927513592	4023/255738	2
WP560	TGF-beta receptor signaling	6/549	48/5488	0.347013136683087	0.893164493849081	0.755459221008634	25805/2022/3624/5054/6696/6772	6
WP4595	Urea cycle and associated pathways	3/549	21/5488	0.351809558188244	0.9003939540072	0.761574065896644	4843/4846/5831	3
WP702	Metapathway biotransformation Phase I and II	12/549	105/5488	0.357723778069414	0.910386918345193	0.770026346642617	1645/9469/1545/56603/1594/1555/1577/1551/9420/64090/9953/4837	12
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/549	13/5488	0.378922848329105	0.911377707608353	0.7708643791552	4312/5743	2
WP2855	Dopaminergic neurogenesis	2/549	13/5488	0.378922848329105	0.911377707608353	0.7708643791552	6469/6571	2
WP4584	Biomarkers for pyrimidine metabolism disorders	2/549	13/5488	0.378922848329105	0.911377707608353	0.7708643791552	1152/1890	2
WP26	S1P receptor signal transduction	3/549	22/5488	0.380243679333286	0.911377707608353	0.7708643791552	2770/23236/8877	3
WP357	Fatty acid biosynthesis	3/549	22/5488	0.380243679333286	0.911377707608353	0.7708643791552	2180/2182/6319	3
WP3845	Canonical and non-canonical Notch signaling	3/549	22/5488	0.380243679333286	0.911377707608353	0.7708643791552	4237/4854/4855	3
WP430	Statin inhibition of cholesterol production	3/549	22/5488	0.380243679333286	0.911377707608353	0.7708643791552	19/348/4023	3
WP4483	Relationship between inflammation, COX-2 and EGFR	3/549	22/5488	0.380243679333286	0.911377707608353	0.7708643791552	4312/51365/5743	3
WP4537	Hippo-Yap signaling pathway	3/549	22/5488	0.380243679333286	0.911377707608353	0.7708643791552	3627/26524/7004	3
WP4585	Cancer immunotherapy by PD-1 blockade	3/549	22/5488	0.380243679333286	0.911377707608353	0.7708643791552	29126/4776/80380	3
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3/549	22/5488	0.380243679333286	0.911377707608353	0.7708643791552	3553/3569/10135	3
WP2332	Interleukin-11 signaling pathway	5/549	41/5488	0.391879012634935	0.934322066966449	0.790271249856599	3383/3589/3673/9021/6772	5
WP4564	Neural crest cell migration during development	4/549	32/5488	0.400037582326826	0.948780234523834	0.802500302931743	1009/2151/4313/8503	4
WP4806	EGFR tyrosine kinase inhibitor resistance	9/549	80/5488	0.407645025241643	0.955896699682699	0.808519574031608	2247/3082/3569/3791/22808/3084/5155/5159/8503	9
WP299	Nuclear receptors in lipid metabolism and toxicity	3/549	23/5488	0.408396892585567	0.955896699682699	0.808519574031608	19/1594/1555	3
WP3935	Leptin-insulin signaling overlap	2/549	14/5488	0.415699006263779	0.955896699682699	0.808519574031608	8503/9021	2
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	2/549	14/5488	0.415699006263779	0.955896699682699	0.808519574031608	3589/3569	2
WP5061	Fatty acid transporters	2/549	14/5488	0.415699006263779	0.955896699682699	0.808519574031608	2180/2182	2
WP691	Tamoxifen metabolism	2/549	14/5488	0.415699006263779	0.955896699682699	0.808519574031608	1545/1577	2
WP241	One-carbon metabolism	3/549	24/5488	0.436150738163255	0.992524064680924	0.839499847900212	10840/2346/10797	3
WP581	EPO receptor signaling	3/549	24/5488	0.436150738163255	0.992524064680924	0.839499847900212	5163/10076/6772	3
WP195	IL-1 signaling pathway	6/549	53/5488	0.439729630852768	0.992524064680924	0.839499847900212	6347/3552/3553/3554/3556/11213	6
WP536	Calcium regulation in cardiac cells	11/549	102/5488	0.443818352952687	0.992524064680924	0.839499847900212	2697/2701/2702/2770/59345/2791/5350/64407/5999/8490/8787	11
WP3	Transcriptional activation by NRF2 in response to phytochemicals	2/549	15/5488	0.451346484159537	0.992524064680924	0.839499847900212	1051/23657	2
WP3927	BMP signaling in eyelid development	2/549	15/5488	0.451346484159537	0.992524064680924	0.839499847900212	6422/6469	2
WP497	Urea cycle and metabolism of amino groups	2/549	15/5488	0.451346484159537	0.992524064680924	0.839499847900212	1152/5831	2
WP5074	Kallmann syndrome	2/549	15/5488	0.451346484159537	0.992524064680924	0.839499847900212	23129/60675	2
WP5149	Lipid metabolism in senescent cells	2/549	15/5488	0.451346484159537	0.992524064680924	0.839499847900212	7941/5743	2
WP205	IL-7 signaling pathway	3/549	25/5488	0.463402184832575	0.999999999107199	0.845823166434345	3559/3575/6772	3
WP5121	Sphingolipid metabolism in senescence	3/549	25/5488	0.463402184832575	0.999999999107199	0.845823166434345	23236/55512/8877	3
WP5053	Development of ureteric collection system	5/549	45/5488	0.473522653549762	0.999999999107199	0.845823166434345	80144/2737/8516/6092/6469	5
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	2/549	16/5488	0.48572293141643	0.999999999107199	0.845823166434345	19/6319	2
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	2/549	16/5488	0.48572293141643	0.999999999107199	0.845823166434345	10631/3371	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/549	16/5488	0.48572293141643	0.999999999107199	0.845823166434345	2180/2182	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/549	16/5488	0.48572293141643	0.999999999107199	0.845823166434345	3569/64386	2
WP3851	TLR4 signaling and tolerance	3/549	26/5488	0.490062835389493	0.999999999107199	0.845823166434345	3569/11213/7099	3
WP5102	Familial partial lipodystrophy (FPLD)	3/549	26/5488	0.490062835389493	0.999999999107199	0.845823166434345	2624/4023/5396	3
WP2839	Hair follicle development: organogenesis - part 2 of 3	3/549	27/5488	0.516058027257421	0.999999999107199	0.845823166434345	3624/6469/7474	3
WP2870	Extracellular vesicle-mediated signaling in recipient cells	3/549	27/5488	0.516058027257421	0.999999999107199	0.845823166434345	3082/7043/7474	3
WP4561	Cell migration and invasion through p75NTR	3/549	27/5488	0.516058027257421	0.999999999107199	0.845823166434345	1009/4313/4915	3
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/549	17/5488	0.518725660995414	0.999999999107199	0.845823166434345	87/3690	2
WP2272	Pathogenic Escherichia coli infection	5/549	48/5488	0.532367868828881	0.999999999107199	0.845823166434345	929/9076/23643/7099/347733	5
WP3942	PPAR signaling pathway	5/549	48/5488	0.532367868828881	0.999999999107199	0.845823166434345	2180/2182/4023/4312/6319	5
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	4/549	38/5488	0.535989809176532	0.999999999107199	0.845823166434345	116443/4915/8503/85358	4
WP143	Fatty acid beta-oxidation	3/549	28/5488	0.541325867849499	0.999999999107199	0.845823166434345	2180/2182/4023	3
WP3529	Zinc homeostasis	3/549	28/5488	0.541325867849499	0.999999999107199	0.845823166434345	4494/4499/55532	3
WP34	Ovarian infertility	2/549	18/5488	0.55028516208751	0.999999999107199	0.845823166434345	1051/2701	2
WP3599	Transcription factor regulation in adipogenesis	2/549	18/5488	0.55028516208751	0.999999999107199	0.845823166434345	1051/3569	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/549	18/5488	0.55028516208751	0.999999999107199	0.845823166434345	8708/8877	2
WP5181	Roles of ceramides in the development of insulin resistance	2/549	18/5488	0.55028516208751	0.999999999107199	0.845823166434345	2180/55512	2
WP5194	Synthesis of ceramides and 1-deoxyceramides	2/549	18/5488	0.55028516208751	0.999999999107199	0.845823166434345	53947/8877	2
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	2/549	19/5488	0.580359510187036	0.999999999107199	0.845823166434345	3091/5163	2
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	6/549	61/5488	0.580755637672938	0.999999999107199	0.845823166434345	5328/4920/6422/6423/83595/7474	6
WP2371	Parkinson's disease pathway	3/549	30/5488	0.58948977752299	0.999999999107199	0.845823166434345	120892/9627/9246	3
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3/549	30/5488	0.58948977752299	0.999999999107199	0.845823166434345	4846/5163/8503	3
WP3858	Toll-like receptor signaling related to MyD88	3/549	30/5488	0.58948977752299	0.999999999107199	0.845823166434345	7097/7099/51311	3
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	3/549	30/5488	0.58948977752299	0.999999999107199	0.845823166434345	6772/7097/7099	3
WP4746	Thyroid hormones production and peripheral downstream signaling effects	7/549	72/5488	0.590352141569968	0.999999999107199	0.845823166434345	50506/405753/3690/23236/6469/6567/7068	7
WP2586	Aryl hydrocarbon receptor pathway	4/549	41/5488	0.597953065033302	0.999999999107199	0.845823166434345	1545/4023/135112/5743	4
WP3580	Methionine de novo and salvage pathway	2/549	20/5488	0.608929560425466	0.999999999107199	0.845823166434345	259307/6898	2
WP4224	Purine metabolism and related disorders	2/549	20/5488	0.608929560425466	0.999999999107199	0.845823166434345	270/316	2
WP5224	2q37 copy number variation syndrome	9/549	95/5488	0.620029121378171	0.999999999107199	0.845823166434345	19/10203/1293/6373/64090/3553/3690/129807/25992	9
WP428	Wnt signaling	8/549	85/5488	0.626622520257198	0.999999999107199	0.845823166434345	4776/5328/23236/166336/4920/6422/6423/7474	8
WP2873	Aryl hydrocarbon receptor pathway	3/549	32/5488	0.634276835559124	0.999999999107199	0.845823166434345	1545/3553/8140	3
WP262	Ebstein-Barr virus LMP1 signaling	2/549	21/5488	0.635994823818858	0.999999999107199	0.845823166434345	6364/9260	2
WP4905	1q21.1 copy number variation syndrome	2/549	21/5488	0.635994823818858	0.999999999107199	0.845823166434345	2697/2702	2
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	2/549	21/5488	0.635994823818858	0.999999999107199	0.845823166434345	2769/23236	2
WP2018	RANKL/RANK signaling pathway	5/549	54/5488	0.63996223431478	0.999999999107199	0.845823166434345	1513/3383/6688/6772/4982	5
WP2881	Estrogen receptor pathway	1/549	10/5488	0.651780638313806	0.999999999107199	0.845823166434345	1545	1
WP3930	EDA signaling in hair follicle development	1/549	10/5488	0.651780638313806	0.999999999107199	0.845823166434345	6469	1
WP4259	Disorders of folate metabolism and transport	1/549	10/5488	0.651780638313806	0.999999999107199	0.845823166434345	10840	1
WP5050	TCA cycle in senescence	1/549	10/5488	0.651780638313806	0.999999999107199	0.845823166434345	5163	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/549	10/5488	0.651780638313806	0.999999999107199	0.845823166434345	629	1
WP5108	Familial  hyperlipidemia type 1	1/549	10/5488	0.651780638313806	0.999999999107199	0.845823166434345	4023	1
WP5176	Disorders of bile acid synthesis and biliary transport	1/549	10/5488	0.651780638313806	0.999999999107199	0.845823166434345	9420	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/549	10/5488	0.651780638313806	0.999999999107199	0.845823166434345	51311	1
WP244	Alpha 6 beta 4 signaling pathway	3/549	33/5488	0.655356651053452	0.999999999107199	0.845823166434345	284217/3908/3915	3
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	6/549	66/5488	0.659067120609425	0.999999999107199	0.845823166434345	283120/5328/4920/6422/6423/7474	6
WP4787	Osteoblast differentiation and related diseases	8/549	88/5488	0.666004798796338	0.999999999107199	0.845823166434345	2247/2252/2737/4854/4855/8503/6772/7474	8
WP286	IL-3 signaling pathway	4/549	45/5488	0.672372249123393	0.999999999107199	0.845823166434345	942/1439/3055/3563	4
WP4566	Translation inhibitors in chronically activated PDGFRA cells	4/549	45/5488	0.672372249123393	0.999999999107199	0.845823166434345	5163/8503/11040/6196	4
WP2884	NRF2 pathway	10/549	110/5488	0.673653007419737	0.999999999107199	0.845823166434345	874/3082/23764/3084/5155/154091/6515/160728/11254/23657	10
WP2267	Synaptic vesicle pathway	3/549	34/5488	0.675550417474521	0.999999999107199	0.845823166434345	6571/6507/6812	3
WP4312	Rett syndrome causing genes	3/549	34/5488	0.675550417474521	0.999999999107199	0.845823166434345	23314/85358/6812	3
WP500	Glycogen synthesis and degradation	3/549	34/5488	0.675550417474521	0.999999999107199	0.845823166434345	3101/5255/5836	3
WP4963	p53 transcriptional gene network	7/549	78/5488	0.67582556546712	0.999999999107199	0.845823166434345	6347/6376/55332/3383/4688/5054/23657	7
WP4357	NRF2-ARE regulation	2/549	23/5488	0.685681656903781	0.999999999107199	0.845823166434345	1051/23657	2
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	2/549	23/5488	0.685681656903781	0.999999999107199	0.845823166434345	3569/114548	2
WP229	Irinotecan pathway	1/549	11/5488	0.686678854736902	0.999999999107199	0.845823166434345	1577	1
WP3871	Valproic acid pathway	1/549	11/5488	0.686678854736902	0.999999999107199	0.845823166434345	1555	1
WP4271	Vitamin B12 disorders	1/549	11/5488	0.686678854736902	0.999999999107199	0.845823166434345	6947	1
WP4788	Autosomal recessive osteopetrosis pathways	1/549	11/5488	0.686678854736902	0.999999999107199	0.845823166434345	29887	1
WP4842	Mammalian disorder of sexual development	1/549	11/5488	0.686678854736902	0.999999999107199	0.845823166434345	30812	1
WP2064	Neural crest differentiation	5/549	57/5488	0.687604328771577	0.999999999107199	0.845823166434345	1004/1280/2247/4854/4855	5
WP2359	Parkin-ubiquitin proteasomal system pathway	5/549	58/5488	0.702499871535761	0.999999999107199	0.845823166434345	834/3310/9627/347733/9246	5
WP4673	Male infertility	8/549	91/5488	0.70280016844467	0.999999999107199	0.845823166434345	56603/2346/4313/4843/4846/29968/8787/6648	8
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4/549	47/5488	0.705819086066231	0.999999999107199	0.845823166434345	1051/1513/6696/4982	4
WP2875	Constitutive androstane receptor pathway	2/549	24/5488	0.708366285880193	0.999999999107199	0.845823166434345	1555/1577	2
WP4698	Vitamin D-sensitive calcium signaling in depression	2/549	24/5488	0.708366285880193	0.999999999107199	0.845823166434345	1594/3786	2
WP4925	Unfolded protein response	2/549	24/5488	0.708366285880193	0.999999999107199	0.845823166434345	3553/7494	2
WP4758	Nephrotic syndrome	3/549	36/5488	0.713286013096035	0.999999999107199	0.845823166434345	8542/5420/7225	3
WP1772	Apoptosis modulation and signaling	7/549	81/5488	0.714105550265755	0.999999999107199	0.845823166434345	597/638/834/3554/4671/5783/8794	7
WP4792	Purine metabolism	1/549	12/5488	0.718085337984929	0.999999999107199	0.845823166434345	270	1
WP5173	Disorders of galactose metabolism 	1/549	12/5488	0.718085337984929	0.999999999107199	0.845823166434345	5836	1
WP697	Estrogen metabolism	1/549	12/5488	0.718085337984929	0.999999999107199	0.845823166434345	1545	1
WP4657	22q11.2 copy number variation syndrome	7/549	82/5488	0.726168112885756	0.999999999107199	0.845823166434345	59/150209/8854/9076/56603/6469/7450	7
WP51	Regulation of actin cytoskeleton	10/549	115/5488	0.727209216350589	0.999999999107199	0.845823166434345	87/929/2149/2247/2252/2335/22808/5155/5159/8503	10
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2/549	25/5488	0.729667512058246	0.999999999107199	0.845823166434345	4915/8503	2
WP2828	Bladder cancer	3/549	37/5488	0.730843632592532	0.999999999107199	0.845823166434345	4312/4313/1890	3
WP3591	Sleep regulation	1/549	13/5488	0.746348878789581	0.999999999107199	0.845823166434345	3569	1
WP3644	NAD+ metabolism	1/549	13/5488	0.746348878789581	0.999999999107199	0.845823166434345	10135	1
WP3853	ERK pathway in Huntington's disease	1/549	13/5488	0.746348878789581	0.999999999107199	0.845823166434345	4915	1
WP4962	Airway smooth muscle cell contraction	1/549	13/5488	0.746348878789581	0.999999999107199	0.845823166434345	23236	1
WP5111	Familial hyperlipidemia type 4	1/549	13/5488	0.746348878789581	0.999999999107199	0.845823166434345	4023	1
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	1/549	13/5488	0.746348878789581	0.999999999107199	0.845823166434345	3091	1
WP2525	Trans-sulfuration and one-carbon metabolism	2/549	26/5488	0.749634568447309	0.999999999107199	0.845823166434345	10797/29968	2
WP4545	Oxysterols derived from cholesterol	2/549	26/5488	0.749634568447309	0.999999999107199	0.845823166434345	9023/9420	2
WP2526	PDGF pathway	3/549	39/5488	0.763408822568695	0.999999999107199	0.845823166434345	5155/5159/6772	3
WP3925	Amino acid metabolism	6/549	74/5488	0.763827182548177	0.999999999107199	0.845823166434345	586/3067/5831/10993/6898/6999	6
WP2643	Nanoparticle-mediated activation of receptor signaling	2/549	27/5488	0.7683206917425	0.999999999107199	0.845823166434345	1277/2335	2
WP2895	Differentiation of white and brown adipocyte	1/549	14/5488	0.771783484368488	0.999999999107199	0.845823166434345	1051	1
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/549	14/5488	0.771783484368488	0.999999999107199	0.845823166434345	283120	1
WP4225	Pyrimidine metabolism and related diseases	1/549	14/5488	0.771783484368488	0.999999999107199	0.845823166434345	1890	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/549	14/5488	0.771783484368488	0.999999999107199	0.845823166434345	3091	1
WP268	Notch signaling	3/549	40/5488	0.778454272012093	0.999999999107199	0.845823166434345	1840/4854/4855	3
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	3/549	40/5488	0.778454272012093	0.999999999107199	0.845823166434345	59/3690/7004	3
WP49	IL-2 signaling pathway	3/549	40/5488	0.778454272012093	0.999999999107199	0.845823166434345	3559/9021/6772	3
WP3676	BDNF-TrkB signaling	2/549	28/5488	0.785781832041962	0.999999999107199	0.845823166434345	4915/7225	2
WP4149	White fat cell differentiation	2/549	28/5488	0.785781832041962	0.999999999107199	0.845823166434345	1051/2624	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	6/549	76/5488	0.785912759636854	0.999999999107199	0.845823166434345	2247/4776/3084/8503/5320/7474	6
WP4290	Metabolic reprogramming in colon cancer	3/549	41/5488	0.792704367299892	0.999999999107199	0.845823166434345	3101/29968/5831	3
WP22	IL-9 signaling pathway	1/549	15/5488	0.794671841526271	0.999999999107199	0.845823166434345	6772	1
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	1/549	15/5488	0.794671841526271	0.999999999107199	0.845823166434345	27122	1
WP4558	Overview of interferons-mediated signaling pathway	1/549	15/5488	0.794671841526271	0.999999999107199	0.845823166434345	6772	1
WP4970	Galanin receptor pathway	1/549	15/5488	0.794671841526271	0.999999999107199	0.845823166434345	3569	1
WP1591	Heart development	2/549	29/5488	0.802075579865562	0.999999999107199	0.845823166434345	4776/6469	2
WP3972	PDGFR-beta pathway	2/549	29/5488	0.802075579865562	0.999999999107199	0.845823166434345	5159/6772	2
WP4223	Ras signaling	12/549	146/5488	0.805108553592056	0.999999999107199	0.845823166434345	2321/59345/2791/3791/22808/4915/5159/8503/51365/5320/115727/7010	12
WP5205	Clock-controlled autophagy in bone metabolism	5/549	67/5488	0.814318368894446	0.999999999107199	0.845823166434345	115908/1513/3569/4982/7474	5
WP61	Notch signaling pathway	4/549	55/5488	0.814665923343623	0.999999999107199	0.845823166434345	1840/3091/4854/4855	4
WP4815	Glycosaminoglycan degradation	1/549	16/5488	0.815268435533594	0.999999999107199	0.845823166434345	8692	1
WP4875	Disruption of postsynaptic signaling by CNV	1/549	16/5488	0.815268435533594	0.999999999107199	0.845823166434345	57555	1
WP5033	Genes associated with the development of rheumatoid arthritis	1/549	16/5488	0.815268435533594	0.999999999107199	0.845823166434345	3559	1
WP3298	Melatonin metabolism and effects	2/549	30/5488	0.817260280032889	0.999999999107199	0.845823166434345	348/1545	2
WP4844	Influence of laminopathies on Wnt signaling	2/549	30/5488	0.817260280032889	0.999999999107199	0.845823166434345	1051/6696	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/549	30/5488	0.817260280032889	0.999999999107199	0.845823166434345	5163/23236	2
WP4630	Measles virus infection	9/549	114/5488	0.818799493452174	0.999999999107199	0.845823166434345	3310/3552/3553/3559/3569/8503/6772/7097/7099	9
WP1971	Integrated cancer pathway	3/549	43/5488	0.818917786720447	0.999999999107199	0.845823166434345	994/4312/6772	3
WP382	MAPK signaling pathway	16/549	193/5488	0.822909390988245	0.999999999107199	0.845823166434345	929/994/1846/2247/2252/3310/3552/3553/3554/120892/22808/4915/5155/5159/115727/7043	16
WP366	TGF-beta signaling pathway	10/549	127/5488	0.830813889588598	0.999999999107199	0.845823166434345	1278/2335/2354/50943/3673/3690/4312/4321/5163/3371	10
WP4971	Phosphoinositides metabolism	3/549	44/5488	0.830933961637783	0.999999999107199	0.845823166434345	23236/5333/113026	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	2/549	31/5488	0.831394305858012	0.999999999107199	0.845823166434345	9586/1511	2
WP325	Triacylglyceride synthesis	1/549	17/5488	0.83380235894223	0.999999999107199	0.845823166434345	4023	1
WP4912	SARS coronavirus and innate immunity	1/549	17/5488	0.83380235894223	0.999999999107199	0.845823166434345	6772	1
WP2355	Corticotropin-releasing hormone signaling pathway	5/549	70/5488	0.84314313474712	0.999999999107199	0.845823166434345	2354/2697/2770/4846/7099	5
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/549	18/5488	0.850479841110154	0.999999999107199	0.845823166434345	22808	1
WP5103	Progeria-associated lipodystrophy	1/549	18/5488	0.850479841110154	0.999999999107199	0.845823166434345	2200	1
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/549	33/5488	0.856740555673066	0.999999999107199	0.845823166434345	3488/5163	2
WP710	DNA damage response (only ATM dependent)	7/549	96/5488	0.858811386003349	0.999999999107199	0.845823166434345	638/197259/5163/8503/5328/6648/7474	7
WP3611	Photodynamic therapy-induced AP-1 survival signaling	3/549	47/5488	0.862953297353013	0.999999999107199	0.845823166434345	2252/3569/4313	3
WP4313	Ferroptosis	4/549	60/5488	0.864211484189908	0.999999999107199	0.845823166434345	2180/2182/1645/23657	4
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/549	19/5488	0.865486526161439	0.999999999107199	0.845823166434345	3002	1
WP185	Integrin-mediated cell adhesion	6/549	85/5488	0.866226168238361	0.999999999107199	0.845823166434345	22801/3673/3678/8516/3687/3690	6
WP69	T-cell receptor signaling pathway	6/549	85/5488	0.866226168238361	0.999999999107199	0.845823166434345	3601/3552/3553/3569/3937/8767	6
WP3286	Copper homeostasis	3/549	48/5488	0.87237769194039	0.999999999107199	0.845823166434345	4494/26872/79689	3
WP363	Wnt signaling pathway	3/549	48/5488	0.87237769194039	0.999999999107199	0.845823166434345	2697/4920/7010	3
WP2034	Leptin signaling pathway	5/549	74/5488	0.875744643381002	0.999999999107199	0.845823166434345	3553/3557/4846/9021/6772	5
WP3940	One-carbon metabolism and related pathways	2/549	35/5488	0.878562308587948	0.999999999107199	0.845823166434345	586/6648	2
WP2878	PPAR-alpha pathway	1/549	20/5488	0.878989524358069	0.999999999107199	0.845823166434345	55554	1
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	1/549	20/5488	0.878989524358069	0.999999999107199	0.845823166434345	597	1
WP4725	Sphingolipid metabolism overview	1/549	20/5488	0.878989524358069	0.999999999107199	0.845823166434345	8877	1
WP5064	7-oxo-C and 7-beta-HC pathways	1/549	20/5488	0.878989524358069	0.999999999107199	0.845823166434345	3290	1
WP2637	Interleukin-1 (IL-1) structural pathway	3/549	49/5488	0.881224812230152	0.999999999107199	0.845823166434345	3552/3554/3556	3
WP2037	Prolactin signaling pathway	5/549	75/5488	0.882935498231599	0.999999999107199	0.845823166434345	3659/4843/6196/9021/6772	5
WP623	Oxidative phosphorylation	2/549	36/5488	0.888284443616884	0.999999999107199	0.845823166434345	3002/56901	2
WP5098	T-cell activation SARS-CoV-2	5/549	76/5488	0.889768085456581	0.999999999107199	0.845823166434345	941/942/3595/8809/3937	5
WP4686	Leucine, isoleucine and valine metabolism	1/549	21/5488	0.891139259385029	0.999999999107199	0.845823166434345	586	1
WP4726	Sphingolipid metabolism: integrated pathway	1/549	21/5488	0.891139259385029	0.999999999107199	0.845823166434345	8877	1
WP127	IL-5 signaling pathway	2/549	37/5488	0.897281061389704	0.999999999107199	0.845823166434345	1439/6772	2
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/549	22/5488	0.902071131819201	0.999999999107199	0.845823166434345	1051	1
WP4482	Vitamin D in inflammatory diseases	1/549	22/5488	0.902071131819201	0.999999999107199	0.845823166434345	3569	1
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	1/549	22/5488	0.902071131819201	0.999999999107199	0.845823166434345	2358	1
WP395	IL-4 signaling pathway	3/549	52/5488	0.904578280833946	0.999999999107199	0.845823166434345	1051/9021/6772	3
WP534	Glycolysis and gluconeogenesis	2/549	38/5488	0.905599709862169	0.999999999107199	0.845823166434345	3101/6515	2
WP35	G protein signaling pathways	5/549	79/5488	0.908245168667336	0.999999999107199	0.845823166434345	2769/2770/2791/5141/5142	5
WP2795	Cardiac hypertrophic response	3/549	53/5488	0.911389227814482	0.999999999107199	0.845823166434345	2247/3084/5320	3
WP1528	Physiological and pathological hypertrophy of the heart	1/549	23/5488	0.91190701704263	0.999999999107199	0.845823166434345	4776	1
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/549	23/5488	0.91190701704263	0.999999999107199	0.845823166434345	5054	1
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	1/549	23/5488	0.91190701704263	0.999999999107199	0.845823166434345	6772	1
WP5180	DYRK1A	3/549	54/5488	0.917756210691462	0.999999999107199	0.845823166434345	2247/3092/26524	3
WP3931	Embryonic stem cell pluripotency pathways	5/549	81/5488	0.919007078432142	0.999999999107199	0.845823166434345	2247/2252/5155/5159/7474	5
WP4917	Proximal tubule transport	2/549	40/5488	0.920382094915073	0.999999999107199	0.845823166434345	760/160728	2
WP3613	Photodynamic therapy-induced unfolded protein response	1/549	24/5488	0.920756614049692	0.999999999107199	0.845823166434345	7494	1
WP4150	Wnt signaling in kidney disease	1/549	24/5488	0.920756614049692	0.999999999107199	0.845823166434345	7474	1
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	1/549	24/5488	0.920756614049692	0.999999999107199	0.845823166434345	9516	1
WP4659	Gastrin signaling pathway	7/549	107/5488	0.921632669659732	0.999999999107199	0.845823166434345	9076/3067/4316/8503/5743/5054/7032	7
WP1403	AMP-activated protein kinase (AMPK) signaling	3/549	55/5488	0.923703727269221	0.999999999107199	0.845823166434345	5209/8503/23236	3
WP4932	7q11.23 copy number variation syndrome	5/549	82/5488	0.923958793251439	0.999999999107199	0.845823166434345	9076/2199/2200/3084/9246	5
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	2/549	41/5488	0.926929670690211	0.999999999107199	0.845823166434345	6347/3569	2
WP314	Fas ligand pathway and stress induction of heat shock proteins	2/549	41/5488	0.926929670690211	0.999999999107199	0.845823166434345	3552/8767	2
WP2038	Microtubule cytoskeleton regulation	2/549	42/5488	0.932966975505821	0.999999999107199	0.845823166434345	2151/4131	2
WP3915	Angiopoietin-like protein 8 regulatory pathway	8/549	123/5488	0.935417087852123	0.999999999107199	0.845823166434345	1555/4023/8503/23433/6196/6319/6567/7068	8
WP1422	Sphingolipid pathway	1/549	26/5488	0.93588202362675	0.999999999107199	0.845823166434345	8877	1
WP2112	IL-17 signaling pathway	1/549	26/5488	0.93588202362675	0.999999999107199	0.845823166434345	1051	1
WP4204	Tumor suppressor activity of SMARCB1	1/549	26/5488	0.93588202362675	0.999999999107199	0.845823166434345	2737	1
WP4838	Regucalcin in proximal tubule epithelial kidney cells	1/549	26/5488	0.93588202362675	0.999999999107199	0.845823166434345	59	1
WP5038	Mitochondrial immune response to SARS-CoV-2	1/549	26/5488	0.93588202362675	0.999999999107199	0.845823166434345	1514	1
WP410	Exercise-induced circadian regulation	2/549	43/5488	0.938530350568522	0.999999999107199	0.845823166434345	1051/50486	2
WP2533	Glycerophospholipid biosynthetic pathway	1/549	27/5488	0.942326690237683	0.999999999107199	0.845823166434345	5320	1
WP2636	Common pathways underlying drug addiction	1/549	27/5488	0.942326690237683	0.999999999107199	0.845823166434345	2770	1
WP3996	Ethanol effects on histone modifications	1/549	27/5488	0.942326690237683	0.999999999107199	0.845823166434345	8854	1
WP408	Oxidative stress response	1/549	27/5488	0.942326690237683	0.999999999107199	0.845823166434345	6648	1
WP1601	Fluoropyrimidine activity	1/549	28/5488	0.948124647948635	0.999999999107199	0.845823166434345	1890	1
WP170	Nuclear receptors	1/549	28/5488	0.948124647948635	0.999999999107199	0.845823166434345	7068	1
WP2583	T cell receptor and co-stimulatory signaling	1/549	28/5488	0.948124647948635	0.999999999107199	0.845823166434345	5163	1
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	3/549	61/5488	0.951840490103171	0.999999999107199	0.845823166434345	2770/23236/6772	3
WP722	Serotonin HTR1 group and FOS pathway	1/549	29/5488	0.953340686094459	0.999999999107199	0.845823166434345	2770	1
WP399	Wnt signaling pathway and pluripotency	4/549	76/5488	0.954188030167391	0.999999999107199	0.845823166434345	120892/4316/5328/7474	4
WP4666	Hepatitis B infection	8/549	132/5488	0.961095769639208	0.999999999107199	0.845823166434345	9586/3569/4776/8503/6772/7043/7097/7099	8
WP2447	Amyotrophic lateral sclerosis (ALS)	1/549	31/5488	0.962254407490742	0.999999999107199	0.845823166434345	834	1
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/549	31/5488	0.962254407490742	0.999999999107199	0.845823166434345	4776	1
WP3981	miRNA regulation of prostate cancer signaling pathways	1/549	31/5488	0.962254407490742	0.999999999107199	0.845823166434345	5159	1
WP5202	Alstrom syndrome	1/549	31/5488	0.962254407490742	0.999999999107199	0.845823166434345	23432	1
WP3584	MECP2 and associated Rett syndrome	2/549	49/5488	0.963731289312591	0.999999999107199	0.845823166434345	2247/6890	2
WP3995	Prion disease pathway	1/549	32/5488	0.96605179255352	0.999999999107199	0.845823166434345	6688	1
WP4906	3q29 copy number variation syndrome	2/549	50/5488	0.966823322819725	0.999999999107199	0.845823166434345	3091/8503	2
WP4396	Nonalcoholic fatty liver disease	8/549	135/5488	0.967350202162068	0.999999999107199	0.845823166434345	6347/3552/3553/3569/56901/8503/9021/7494	8
WP400	p38 MAPK signaling pathway	1/549	33/5488	0.969467768706034	0.999999999107199	0.845823166434345	6772	1
WP4874	CAMKK2 pathway	1/549	33/5488	0.969467768706034	0.999999999107199	0.845823166434345	3383	1
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	1/549	33/5488	0.969467768706034	0.999999999107199	0.845823166434345	6772	1
WP4205	MET in type 1 papillary renal cell carcinoma	2/549	51/5488	0.969661088783238	0.999999999107199	0.845823166434345	3082/8503	2
WP2853	Endoderm differentiation	6/549	110/5488	0.970383514393918	0.999999999107199	0.845823166434345	1846/3915/6422/154091/83595/6772	6
WP585	Interferon type I signaling pathways	2/549	52/5488	0.97226440110121	0.999999999107199	0.845823166434345	9021/6772	2
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	3/549	68/5488	0.972365221294481	0.999999999107199	0.845823166434345	9423/5743/7043	3
WP313	Hepatocyte growth factor receptor signaling	1/549	34/5488	0.972540581718021	0.999999999107199	0.845823166434345	3082	1
WP2369	Histone modifications	1/549	35/5488	0.975304648574788	0.999999999107199	0.845823166434345	80854	1
WP4262	Breast cancer pathway	6/549	115/5488	0.978721314791107	0.999999999107199	0.845823166434345	2247/2252/4854/4855/8503/7474	6
WP5085	Vasopressin-regulated water reabsorption	1/549	37/5488	0.980027325665995	0.999999999107199	0.845823166434345	9586	1
WP5124	Alzheimer's disease	13/549	208/5488	0.980353224961909	0.999999999107199	0.845823166434345	348/1139/3552/3553/3569/4023/4843/8503/23236/5743/347733/7474/7494	13
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	2/549	56/5488	0.980681744461501	0.999999999107199	0.845823166434345	3937/5163	2
WP2059	Alzheimer's disease and miRNA effects	13/549	210/5488	0.982321170993511	0.999999999107199	0.845823166434345	348/1139/3552/3553/3569/4023/4843/8503/23236/5743/347733/7474/7494	13
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	6/549	119/5488	0.98376273798862	0.999999999107199	0.845823166434345	249/4688/4776/4915/6696/6772	6
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	1/549	39/5488	0.983848177036196	0.999999999107199	0.845823166434345	7043	1
WP4155	Endometrial cancer	2/549	59/5488	0.98531141633458	0.999999999107199	0.845823166434345	2247/8503	2
WP5220	Metabolic reprogramming in pancreatic cancer	1/549	40/5488	0.9854755124752	0.999999999107199	0.845823166434345	8140	1
WP231	TNF-alpha signaling pathway	4/549	92/5488	0.986106494496331	0.999999999107199	0.845823166434345	6347/3569/5836/6401	4
WP4861	Endoplasmic reticulum stress response in coronavirus infection	1/549	41/5488	0.986939158519824	0.999999999107199	0.845823166434345	7494	1
WP481	Insulin signaling	8/549	150/5488	0.986977373503935	0.999999999107199	0.845823166434345	30846/8503/57381/23433/6196/9021/6812/7494	8
WP4321	Thermogenesis	4/549	93/5488	0.987141299242732	0.999999999107199	0.845823166434345	2180/2182/9586/6196	4
WP4549	Fragile X syndrome	4/549	93/5488	0.987141299242732	0.999999999107199	0.845823166434345	4131/4915/5163/23236	4
WP4685	Melanoma	2/549	61/5488	0.987778195447894	0.999999999107199	0.845823166434345	3791/8503	2
WP254	Apoptosis	3/549	80/5488	0.989736476731494	0.999999999107199	0.845823166434345	834/3002/3659	3
WP437	EGF/EGFR signaling pathway	8/549	154/5488	0.989921084077022	0.999999999107199	0.845823166434345	54206/2354/2697/4846/7837/6196/6772/6812	8
WP4263	Pancreatic adenocarcinoma pathway	3/549	82/5488	0.991333249247352	0.999999999107199	0.845823166434345	8503/6772/7043	3
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	2/549	65/5488	0.991560938507175	0.999999999107199	0.845823166434345	4023/6319	2
WP4255	Non-small cell lung cancer	2/549	66/5488	0.992311217627044	0.999999999107199	0.845823166434345	5163/8503	2
WP4656	Joubert syndrome	2/549	66/5488	0.992311217627044	0.999999999107199	0.845823166434345	27077/6469	2
WP3680	Physico-chemical features and toxicity-associated pathways	1/549	52/5488	0.995945340129881	0.999999999107199	0.845823166434345	2335	1
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	1/549	52/5488	0.995945340129881	0.999999999107199	0.845823166434345	3627	1
WP3594	Circadian rhythm genes	6/549	142/5488	0.996861272790617	0.999999999107199	0.845823166434345	56938/3569/10135/4843/60675/5054	6
WP183	Proteasome degradation	1/549	55/5488	0.997054112430092	0.999999999107199	0.845823166434345	5698	1
WP673	ErbB signaling pathway	2/549	77/5488	0.997272441456641	0.999999999107199	0.845823166434345	3084/8503	2
WP304	Kit receptor signaling pathway	1/549	56/5488	0.997351791847703	0.999999999107199	0.845823166434345	6772	1
WP3651	Pathways affected in adenoid cystic carcinoma	1/549	57/5488	0.997619440278412	0.999999999107199	0.845823166434345	4603	1
WP2261	Glioblastoma signaling pathways	2/549	80/5488	0.997951121447134	0.999999999107199	0.845823166434345	54206/5159	2
WP5072	Modulators of TCR signaling and T cell activation	1/549	59/5488	0.998076438697389	0.999999999107199	0.845823166434345	3937	1
WP4536	Genes related to primary cilium development (based on CRISPR)	2/549	84/5488	0.998603792119428	0.999999999107199	0.845823166434345	27077/23552	2
WP2857	Mesodermal commitment pathway	3/549	112/5488	0.999382545595441	0.999999999107199	0.845823166434345	3624/4211/154091	3
WP4022	Pyrimidine metabolism	1/549	75/5488	0.999651483290918	0.999999999107199	0.845823166434345	1890	1
WP4803	Ciliopathies	3/549	126/5488	0.999829285157062	0.999999999107199	0.845823166434345	27077/2737/23432	3
WP477	Cytoplasmic ribosomal proteins	1/549	84/5488	0.99986698608122	0.999999999107199	0.845823166434345	6196	1
WP2446	Retinoblastoma gene in cancer	1/549	86/5488	0.999892641660192	0.999999999107199	0.845823166434345	994	1
WP179	Cell cycle	2/549	113/5488	0.999918256785298	0.999999999107199	0.845823166434345	994/7043	2
WP23	B cell receptor signaling pathway	1/549	95/5488	0.99995911072455	0.999999999107199	0.845823166434345	1380	1
WP4352	Ciliary landscape	1/549	194/5488	0.999999999107199	0.999999999107199	0.845823166434345	3934	1
